Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
The brain-to-pancreatic islet neuronal map reveals differential glucose regulation from distinct hypothalamic regions
GLP-1GLP-1 2
Agonists Exendin-4 (subsequently renamed exenatide, the first FDA approved incretin mimetic), Liraglutide (a longacting DPP-4-resistant GLP-1 receptor agonist), CJC-1131 (a GLP-1 analog engineered for covalent coupling to albumin), Albiglutide (originally referred to as albugon, a recombinant human albumin-GLP-1 protein), ZP10 (an exendin-4 derivative), BIM51077 (subsequently renamed taspoglutide), LY315902 (a DPP-4-resistant GLP-1 analog), LY2428757 (a pegylated GLP-1), LY2199265 (Dulaglutide, an Fc immunoglobulin fusion protein), Semaglutide (a synthetic peptide similar to GLP-1), Lixisenatide (a synthetic peptide similar to exandin-4), and Tirzepatide (LY3298176, a dual agonist of GIP and GLP-1 receptors)
- Report any side effects or concerns to your doctor immediately
US$ 27.37
US$ 22.83
US$ 25.73
US$ 23.31
US$ 22.19
US$ 24.59
US$ 29.17
US$ 28.31
US$ 21.53
US$ 28.45
US$ 21.16
US$ 21.74
